Clinical trial
Treatment Strategies for Juvenile Idiopathic Arthritis Patients With Sustained Inactive Disease: A Phase 4, Multicentre, Randomised Trial Comparing Maintenance Versus Tapered TNF Alpha Inhibitor Monotherapy - the Treat-JIA Trial
NCT07904780 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Strategies for Juvenile Idiopathic Arthritis Patients With Sustained Inactive Disease: A Phase 4, Multicentre, Randomised Trial Comparing Maintenance Versus Tapered TNF Alpha Inhibitor Monotherapy - the Treat-JIA Trial
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- November 11, 2026
- Completion date
- November 11, 2030
- Enrollment
- 90 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile idiopathic arthritis (jia)
Arms
As registered; 2 arms.
-
Stable TNF-inhibitor monotherapy
Continued TNF-inhibitor therapy at a stable dose. This can be adalimumab, etanercept or golimumab.
-
TNF-inhibitor withdrawal
Doubled treatment interval of the TNF-inhibitor therapy for 4 months, then subsequent withdraw of the TNF-inhibitor therapy.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Proportion of disease flare
Disease flare is defined as a combination of: A clinical significant increase in Juvenile Arthritis Disease Activity Score 27 (JADAS-27\*) ≥1.7 from baseline AND active joints ≥1 (swollen, or tender + limited range of motion) OR consensus between treating physician and participant/parents that a clinically significant flare has occurred with need of intensification of antirheumatic treatment.
Lead sponsor's other trials
Oslo University Hospital, most recent start first.
+828 more trials See the organization page
Similar trials
Same condition (Arthritis, Juvenile) and phase, most recent start first.
+19 more trials See the condition page